The Supervisory Board of PharmAccess Group is pleased to announce the appointment of Nicole Spieker as Chief Executive Officer (CEO) of PharmAccess, effective 1 November 2021. Spieker will lead PharmAccess Group into the next phase of its mission to improve healthcare in Sub-Saharan Africa, utilizing innovative strategies such as mobile technology and sustainable financing models, enabling access to care for all.
Earlier this year, current CEO Monique Dolfing-Vogelenzang announced that she would step down after 13 years of service. The Supervisory Board has since then undertaken a thorough process to search for the ideal successor, considering both external and internal candidates. In consultation with senior PharmAccess colleagues, Nicole Spieker emerged as the unanimous first choice.